Jones Financial Companies
FENC icon

Jones Financial Companies’s Fennec Pharmaceuticals FENC Stock Holding History

Jones Financial Companies’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
26,052
+1,100
+4% +$8.98K ﹤0.01% 2433
2026
Q1 		$147K Hold
24,952
– – ﹤0.01% 2507
2025
Q4 		$192K Buy
24,952
+15,552
+165% +$128K ﹤0.01% 1926
2025
Q3 		$85K Sell
9,400
-150
-2% -$1.3K ﹤0.01% 2142
2025
Q2 		$78.8K Buy
9,550
+700
+8% +$4.79K ﹤0.01% 2035
2025
Q1 		$57.5K Buy
8,850
+1,900
+27% +$12.2K ﹤0.01% 1999
2024
Q4 		$43.9K Buy
6,950
+1,200
+21% +$6.15K ﹤0.01% 1925
2024
Q3 		$29.9K Buy
5,750
+5,100
+785% +$29.5K ﹤0.01% 1820
2024
Q2 		$3.97K Buy
+650
New +$5.4K ﹤0.01% 1993

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jones Financial Companies's FENC Position: Q2 2026 in Review

Jones Financial Companies increased its Fennec Pharmaceuticals (FENC) stake by 4.4% in Q2 2026, buying an estimated $8.98K and bringing the position to 26,052 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2433.

Jones Financial Companies first reported a position in FENC in Q2 2024 and has held it in 9 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Jones Financial Companies held 26,052 shares of Fennec Pharmaceuticals worth $287K as of Q2 2026.
  • Jones Financial Companies bought 1,100 Fennec Pharmaceuticals shares in Q2 2026, an estimated $8.98K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2433 holding.
  • Jones Financial Companies first reported a position in Fennec Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.